Comparable stake leader
Knight Therapeutics Inc.
SEC ownership of Synergy CHC Corp.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001562733.
Disclosed value leader
Jack Ross
Comparable rows
15/19
Latest evidence
21 Apr 2026
- Symbol
- SNYR on Nasdaq
- Ownership evidence mix
- 3/4/5, 13D/G, and 13F
- Largest current holder
- Knight Therapeutics Inc.
- Latest large-stake holder
- Knight Therapeutics Inc.
- Latest evidence date
- 21 Apr 2026
- CIK
- 0001562733
- Location
- Westbrook, ME
Ownership snapshot
2 facts
Issuer identity
2 facts
Ownership snapshot
Top shareholders of Synergy CHC Corp. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Knight Therapeutics Inc.
Disclosed value leader
Jack Ross
Comparable rows
15/19
Latest evidence
21 Apr 2026
3/4/5
13D/G
13F
Lead comparable stake: 20%
4 rows are not safely comparable across share classes.
13D/G row: Knight Therapeutics Inc.
Showing 1-8 of 19 holder rows.
Quick read
Knight Therapeutics Inc. leads the comparable SEC ownership view at 20%.
15 of 19 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Knight Therapeutics Inc.
20%
Nitin Kaushal
3.2%
Teresa Brigid Thompson
0.27%
GRATIA CAPITAL, LLC
5.7%
HEARTLAND ADVISORS INC
5.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 19 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Knight Therapeutics Inc. |
3/4/5
13D/G
10%+ Owner
|
20%
from 13D/G
|
$6,020,347
1,911,414 shares
mixed-class rows
|
— | 11 Jun 2025 |
| Nitin Kaushal |
3/4/5
Director
|
3.2%
|
$353,930
306,433 shares
|
— | 21 Apr 2026 |
| Teresa Brigid Thompson |
3/4/5
Director
|
0.27%
|
$29,826
25,824 shares
|
— | 21 Apr 2026 |
| GRATIA CAPITAL, LLC |
13F
Company
|
5.7%
|
$709,500
550,000 shares
|
— | 31 Mar 2026 |
| HEARTLAND ADVISORS INC |
13F
Company
|
5.7%
|
$709,500
550,000 shares
|
— | 31 Mar 2026 |
| SANDERS MORRIS HARRIS LLC |
13F
Company
|
4.3%
|
$535,933
415,452 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.93%
|
$115,803
89,770 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.24%
|
$29,862
23,149 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$109,414.
Buys
$109,414
Insiders: 1
Sells
$0
Insiders: 0
Net
+$109,414
Shares: +44,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 44,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 44,000 | 0 | $109,414 | $0 | +$109,414 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-9 of 9 reporting-owner rows connected to Synergy CHC Corp.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
9
Largest current holder
Jack Ross
Net 12M change
+$109,415
Latest report
21 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jack Ross | CEO and Chairman, Director, 10%+ Owner | $15,240,601 | +$109,415 | +0.72% | Mixed | 18 Sep 2025 |
| Knight Therapeutics Inc. | 10%+ Owner | $6,020,347 | Mixed | 11 Jun 2025 | ||
| James Paul SoRelle | Director | $442,390 | Mixed | 22 Oct 2024 | ||
| Nitin Kaushal | Director | $353,930 | Mixed | 21 Apr 2026 | ||
| Teresa Brigid Thompson | Director | $29,826 | Mixed | 21 Apr 2026 | ||
| Scott Woodburn | Director | Mixed | 22 Oct 2024 | |||
| Alfred Baumeler | President, Director | Mixed | 18 Sep 2025 | |||
| Stacy B. McLaughlin | Chief Financial Officer | Mixed | 22 Oct 2024 | |||
| Jaime Fickett | Chief Financial Officer | Mixed | 18 Sep 2025 |
Recent insider transactions for Synergy CHC Corp.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Nitin Kaushal | SNYR | Common Stock, par value $0.00001 per share | Award | 306,433 | 306,433 | 21 Apr 2026 | Direct | |||
| Teresa Brigid Thompson | SNYR | Common Stock, par value $0.00001 per share | Award | 25,824 | 25,824 | 21 Apr 2026 | Direct | |||
| Alfred Baumeler | SNYR | Stock option (right to buy) | Award | 150,000 | 150,000 | 18 Sep 2025 | Direct | |||
| Jaime Fickett | SNYR | Stock option (right to buy) | Award | 150,000 | 150,000 | 18 Sep 2025 | Direct | |||
| Jack Ross | SNYR | Stock option (right to buy) | Award | 750,000 | 750,000 | 18 Sep 2025 | By Kenek Brands Inc. | |||
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.02% | $369 | $3.69 | 100 | 410,507 | 30 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.06% | $915 | $3.66 | 250 | 410,407 | 29 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.09% | $1,365 | $3.90 | 350 | 410,157 | 25 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.07% | $1,149 | $3.83 | 300 | 409,807 | 24 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.07% | $1,062 | $3.54 | 300 | 409,507 | 22 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.18% | $2,400 | $3.20 | 750 | 409,207 | 11 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.34% | $4,466 | $3.19 | 1,400 | 408,457 | 10 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.1% | $1,260 | $3.15 | 400 | 407,057 | 09 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.2% | $2,688 | $3.36 | 800 | 406,657 | 08 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.17% | $2,282 | $3.26 | 700 | 405,857 | 07 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.43% | $5,635 | $3.22 | 1,750 | 405,157 | 03 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.94% | $12,112 | $3.23 | 3,750 | 403,407 | 02 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.06% | $762 | $3.05 | 250 | 399,657 | 01 Jul 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.66% | $6,994 | $2.69 | 2,600 | 399,407 | 30 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.03% | $260 | $2.60 | 100 | 396,807 | 27 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.16% | $1,658 | $2.55 | 650 | 396,707 | 26 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.15% | $1,578 | $2.63 | 600 | 396,057 | 24 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.1% | $1,044 | $2.61 | 400 | 395,457 | 23 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 2.68% | $26,780 | $2.60 | 10,300 | 395,057 | 20 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.16% | $1,338 | $2.23 | 600 | 384,757 | 18 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.03% | $248 | $2.48 | 100 | 384,157 | 17 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.12% | $1,026 | $2.28 | 450 | 384,057 | 16 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.03% | $215 | $2.15 | 100 | 383,607 | 13 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.24% | $1,971 | $2.19 | 900 | 383,507 | 11 Jun 2025 | Direct |
| Knight Therapeutics Inc | SNYR | Pre-Funded Common Stock Purchase Warrant | Purchase | 428,570 | 428,570 | 11 Jun 2025 | See footnote | |||
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.31% | $2,568 | $2.14 | 1,200 | 382,607 | 10 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.18% | $1,519 | $2.17 | 700 | 381,407 | 09 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.21% | $1,624 | $2.03 | 800 | 380,707 | 05 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.42% | $3,312 | $2.07 | 1,600 | 379,907 | 04 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 2.55% | $16,638 | $1.77 | 9,400 | 378,307 | 03 Jun 2025 | Direct |
| Jack Ross | SNYR | Common Stock, par value $0.00001 per share | Purchase | 0.65% | $4,176 | $1.74 | 2,400 | 368,907 | 02 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.